MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Sydenham’s chorea: Clinical features and treatment outcome

    S. Pandey, P. Rani (New Delhi, India)

  • Symptomatic delayed-onset edema following deep brain stimulation for Parkinson’s disease: occurrence, symptoms, management and outcomes. Experience of a single center.

    B. Minafra, NG. Pozzi, M. Picascia, R. Zangaglia, F. Bruschi, F. Avantaggiato, M. Todisco, D. Servello, C. Pacchetti (Pavia, Italy)

  • Symptomatic palatal tremor combined with unilateral limb tremor and parkinsonism

    SK. Song, JH. Kang (Jeju-Si, Republic of Korea)

  • Symptomatic treatment of hereditary spastic paraplegias with fampridine: a pilot study

    M. Rosário, J. Ferreira, J. Ferro, L. Guedes (Lisbon, Portugal)

  • Synaptic dysfuncion in a Drosophila model of PARK14

    T. Hatano, A. Mori, T. Inoshita, K. Fukushima-Shiba, T. Koinuma, C. Yamashita, Y. Imai, N. Hattori (Tokyo, Japan)

  • Synaptic function in Parkinson’s disease associated with GBA mutations

    T. Eid, R. Bandopadhyay, T. Lashley, J. Hardy, J. Holton, T. Warner, P. Francis (London, United Kingdom)

  • Synchronization Study of Regional Local Field Potential in Rat with Dopamine Receptor Stimulation

    SH. Lin, SY. Chen, YY. Chen (Hualien, Taiwan)

  • Synuclein-alpha´s variant, rs 894280 shows association with memory and attention in PD patients

    O. Monchi, JR. Sarna, D. Martino, Z. Gan-Or, JA. Ruskey, T. Alrazi, A. Robichaud, T. Hammer, ST. Lang, J. Cheetham, E. Yoon, M. Kibreab, I. Kathol, JS. Provost, M. Ramezani (Calgary, AB, Canada)

  • Systematic Assessment of 10 diagnostic marker candidates in biological fluids for Parkinson’s disease

    B. Mollenhauer, R. Gera, N. Kruse, R. Barbour, W. Zago, S. Schade, B. Otte, C. Trenkwalder (South San Francisco, CA, USA)

  • Systematic review of Mucuna Pruriens as a treatment for Parkinson’s disease

    TH. Boonmongkol, O. Phokaewvarangkul, S. Vimolmangkang, R. Bhidayasiri (Bangkok, Thailand)

  • « Previous Page
  • 1
  • …
  • 185
  • 186
  • 187
  • 188
  • 189
  • …
  • 217
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley